Professor Dirk de Ruysscher
Professor Dr Dirk De Ruysscher earned his medical degree at the University of Leuven, Belgium, in
1986 and became Radiation Oncologist at the same university in 1991. In 1992, he obtained his
PhD thesis at the University of Leuven on the influence of radiotherapy on immunity.
Dr De Ruysscher specialises in lung cancer, in which he pioneered the integration of molecular imaging
in radiation treatment planning and individualised radiotherapy schedules. He is actively involved
in the ETOP and the ESMO where he is involved in the ELCC and the ESMO NSCLC track.
Dr De Ruysscher coordinated work-packages in several academic international (EU), Dutch and Belgian
research projects, as well as co-operations with industrial partners such as Siemens, Philips,
DSM and BMS. He heads of the Division Maastro Clinical Trials and was coordinator of the biobank
project at Maastro Clinic that was able to include over 6000 patients for radiogenomic studies.
He has supervised many PhD projects, and was or is the study coordinator of 9 phase I studies,
20 phase II and 5 phase III trials, dealing with individualised radiation-dose escalation, combining
targeted agents with radiotherapy, the development of new PET tracers, molecular pathways involved
in radiation damage, individualized radiotherapy, proton therapy, meta-analyses, cost-effectiveness,
immune therapy and PCI.
Dr De Ruysscher has published over 200 peer-reviewed Wi-1 papers and chapters in several scientific
He is full Professor of Respiratory Oncology at the Maastricht University Medical Center, Maastricht,
The Netherlands, and full Professor of Radiation Oncology at the University of Leuven, Belgium